Personalized medicine is the right drug for the disease to the right patient at the right time. If we can get this kind of information available in real time to physicians, it would allow us potentially to be able to look -- before we gave the drug to individuals -- for those type of reactions.

These are the kind of people who meet those Piper requirements, integrating across multiple research teams and working with investigators from multiple institutions. They would be a perfect fit for that kind of program.